《高盛认股证牛熊证》医药股备受关注 留意高杠杆少数高敏感度平医购21302、石药购17777
板块动向：受中国新型冠状病毒疫情影响下，医药股受市场密切关注，近期股价普遍造好。石药(1093)
正股表现：石药昨日升约1%，今早继续上升，19.52元，升约0.8%，暂时为连续第五日上升，累计至今升约13%。
资金流向：观察个股认股证资金流向，过去5个交易日共录得约990万元资金流入认购证。
产品选择：投资者如看好，可留意年期约5个月，属行使价19.5至21.5元间认购证中，杠杆最突出的石药购17777。以及可留意年期约3个月，杠杆较高的价外石药购12919。
石药购17777，行使价21.23元，2020年06月24日到期，实际杠杆5.4倍，行使价19.5至21.5元间产品中，杠杆最高
石药购12919，行使价23.68元，2020年05月11日到期，实际杠杆7.7倍，价外、高杠杆
平安好医生(1833)
正股表现：平安好医生昨日重上70元水平，收市升约4.4%。今早继续上升，现报72.9元，升约1.4%，暂时为连续第四日上升，累计至今升约10%。平安好医生将於下周二公布业绩。
资金流向：观察个股认股证资金流向，可见本周资金倾向部署认购证，过去4个交易日共录得约330万元资金流入
产品选择：投资者如看好，可留意年期约6个月，属市场上少数面值低於0.25元的平医购21302。
平医购21302，行使价88.88元，2020年07月31日到期，实际杠杆3.5倍，市场上少数面值低於0.25元认购证
注: 以上数据资料来自高盛认股证牛熊证网站~重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
